67 related articles for article (PubMed ID: 7986335)
41. Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells.
Galea-Lauri J; Darling D; Gan SU; Krivochtchapov L; Kuiper M; Gäken J; Souberbielle B; Farzaneh F
J Immunol; 1999 Jul; 163(1):62-70. PubMed ID: 10384100
[TBL] [Abstract][Full Text] [Related]
42. Comparison of changes in the percentages of CD8+CD28-TCRalpha beta+ T cell subpopulations in allergic asthma subjects vs controls before and after anti-CD3/anti-CD28/IL-2 stimulation in vitro.
Eusebio M; Kraszula L; Kupczyk M; Kuna P; Pietruczuk M
J Biol Regul Homeost Agents; 2013; 27(4):969-79. PubMed ID: 24382178
[TBL] [Abstract][Full Text] [Related]
43. Evidence for intact costimulation via CD28 and CD27 molecules in hyporesponsive T cells from human immunodeficiency virus-infected individuals.
Meyaard L; Kuiper H; Otto SA; Wolthers KC; van Lier RA; Miedema F
Eur J Immunol; 1995 Jan; 25(1):232-7. PubMed ID: 7531146
[TBL] [Abstract][Full Text] [Related]
44. Ligation of the CD5 or CD28 molecules on resting human T cells induces expression of the early activation antigen CD69 by a calcium- and tyrosine kinase-dependent mechanism.
Vandenberghe P; Verwilghen J; Van Vaeck F; Ceuppens JL
Immunology; 1993 Feb; 78(2):210-7. PubMed ID: 7682535
[TBL] [Abstract][Full Text] [Related]
45. Activated long-term peripheral blood cultures as preparation for adoptive alloreactive cell therapy in cancer patients.
Morecki S; Gelfand Y; Levi S; Nagler A; Condiotti R; Nabet C; Ackerstein A; Slavin S
J Hematother; 1997 Apr; 6(2):115-24. PubMed ID: 9131440
[TBL] [Abstract][Full Text] [Related]
46. Co-stimulatory pathways controlling activation and peripheral tolerance of human CD4+CD28- T cells.
Park W; Weyand CM; Schmidt D; Goronzy JJ
Eur J Immunol; 1997 May; 27(5):1082-90. PubMed ID: 9174596
[TBL] [Abstract][Full Text] [Related]
47. Restoration of functional defects in peripheral blood mononuclear cells isolated from cancer patients by thiol antioxidants alpha-lipoic acid and N-acetyl cysteine.
Mantovani G; Macciò A; Melis G; Mura L; Massa E; Mudu MC
Int J Cancer; 2000 Jun; 86(6):842-7. PubMed ID: 10842199
[TBL] [Abstract][Full Text] [Related]
48. Effect of stress on interleukin-2 receptor expression by bovine mononuclear leukocytes.
Lan HC; Reddy PG; Chambers MA; Walker G; Srivastava KK; Ferguson JA
Vet Immunol Immunopathol; 1995 Dec; 49(3):241-9. PubMed ID: 8746698
[TBL] [Abstract][Full Text] [Related]
49. [Suppressive effect of glycopeptidolipid from Mycobacterium avium-intracellulare complex serovar 4 and 16 on blastogenesis of human peripheral blood mononuclear cells].
Fukui J
Kekkaku; 1998 Jan; 73(1):5-12. PubMed ID: 9494339
[TBL] [Abstract][Full Text] [Related]
50. mIL-2R, T cell subsets & hepatitis C.
Li CP; Wang KX; Wang J; Pan BR
World J Gastroenterol; 2002 Apr; 8(2):298-300. PubMed ID: 11925611
[TBL] [Abstract][Full Text] [Related]
51. Single Cell Analysis of Blood Mononuclear Cells Stimulated Through Either LPS or Anti-CD3 and Anti-CD28.
Lawlor N; Nehar-Belaid D; Grassmann JDS; Stoeckius M; Smibert P; Stitzel ML; Pascual V; Banchereau J; Williams A; Ucar D
Front Immunol; 2021; 12():636720. PubMed ID: 33815388
[TBL] [Abstract][Full Text] [Related]
52. Increased Spontaneous Programmed Cell Death Is Associated with Impaired Cytokine Secretion in Peripheral Blood Mononuclear Cells from Hepatitis C Virus-Positive Patients.
Alhetheel A; Albarrag A; Shakoor Z; Alswat K; Abdo A; Al-Hamoudi W; Alomar S
Viral Immunol; 2017 May; 30(4):283-287. PubMed ID: 28304236
[TBL] [Abstract][Full Text] [Related]
53. A Synopsis of Hepatitis C Virus Treatments and Future Perspectives.
Medina C; García AH; Crespo FI; Toro FI; Mayora SJ; De Sanctis JB
Curr Issues Mol Biol; 2023 Oct; 45(10):8255-8276. PubMed ID: 37886964
[TBL] [Abstract][Full Text] [Related]
54. mRNA cytokine profile in peripheral blood cells from chronic hepatitis C virus (HCV)-infected patients: effects of interferon-alpha (IFN-alpha) treatment.
Shapiro S; Gershtein V; Elias N; Zuckerman E; Salman N; Lahat N
Clin Exp Immunol; 1998 Oct; 114(1):55-60. PubMed ID: 9764603
[TBL] [Abstract][Full Text] [Related]
55. CD3- and CD28-activating pathways in HCV infection.
Corado JA; Toro FI; Baroja ML; Bianco NE; Machado IV
Viral Immunol; 1994; 7(1):37-40. PubMed ID: 7986335
[TBL] [Abstract][Full Text] [Related]
56. Regulation of NF-kappa B nuclear activity in peripheral blood mononuclear cells: role of CD28 antigen.
Romano MF; Bisogni R; Lamberti A; Turco MC; Petrella A; Tassone P; Van Lier R; Formisano S; Venuta S
Cell Immunol; 1994 Jul; 156(2):371-7. PubMed ID: 8025954
[TBL] [Abstract][Full Text] [Related]
57. Enhancement by interleukin 4 of interleukin 2- or antibody-induced proliferation of lymphocytes from interleukin 2-treated cancer patients.
Treisman J; Higuchi CM; Thompson JA; Gillis S; Lindgren CG; Kern DE; Ridell SR; Greenberg PD; Fefer A
Cancer Res; 1990 Feb; 50(4):1160-4. PubMed ID: 2153452
[TBL] [Abstract][Full Text] [Related]
58. CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes.
Turka LA; Ledbetter JA; Lee K; June CH; Thompson CB
J Immunol; 1990 Mar; 144(5):1646-53. PubMed ID: 2155264
[TBL] [Abstract][Full Text] [Related]
59. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
[TBL] [Abstract][Full Text] [Related]
60. Regulation of interleukin-12 receptor beta1 chain expression and interleukin-12 binding by human peripheral blood mononuclear cells.
Wu C; Warrier RR; Wang X; Presky DH; Gately MK
Eur J Immunol; 1997 Jan; 27(1):147-54. PubMed ID: 9022011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
